loading
前日終値:
$337.27
開ける:
$336.79
24時間の取引高:
195.81K
Relative Volume:
0.53
時価総額:
$7.45B
収益:
-
当期純損益:
$-518.67M
株価収益率:
-13.05
EPS:
-25.12
ネットキャッシュフロー:
$-438.32M
1週間 パフォーマンス:
-4.02%
1か月 パフォーマンス:
-2.34%
6か月 パフォーマンス:
+54.34%
1年 パフォーマンス:
+22.78%
1日の値動き範囲:
Value
$324.02
$336.79
1週間の範囲:
Value
$324.02
$350.50
52週間の値動き範囲:
Value
$189.00
$377.46

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
名前
Madrigal Pharmaceuticals Inc
Name
セクター
Healthcare (1166)
Name
電話
404-380-9263
Name
住所
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
職員
0
Name
Twitter
@MadrigalPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
MDGL's Discussions on Twitter

MDGL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MDGL
Madrigal Pharmaceuticals Inc
327.87 7.45B 0 -518.67M -438.32M -25.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-28 アップグレード B. Riley Securities Neutral → Buy
2025-02-27 繰り返されました H.C. Wainwright Buy
2024-06-28 開始されました Cantor Fitzgerald Neutral
2024-06-11 開始されました Wolfe Research Outperform
2024-04-22 開始されました BofA Securities Underperform
2024-03-15 アップグレード B. Riley Securities Sell → Neutral
2024-03-06 開始されました Citigroup Buy
2024-02-26 ダウングレード B. Riley Securities Neutral → Sell
2022-12-20 繰り返されました Oppenheimer Outperform
2022-12-19 繰り返されました H.C. Wainwright Buy
2022-12-19 繰り返されました Piper Sandler Overweight
2022-12-19 アップグレード Raymond James Underperform → Mkt Perform
2022-07-08 ダウングレード B. Riley Securities Buy → Neutral
2021-10-07 開始されました Jefferies Buy
2021-08-06 アップグレード BMO Capital Markets Market Perform → Outperform
2021-05-20 再開されました Goldman Buy
2020-11-24 再開されました Evercore ISI Outperform
2020-11-06 繰り返されました H.C. Wainwright Buy
2020-07-31 開始されました Piper Sandler Overweight
2020-06-05 開始されました BMO Capital Markets Market Perform
2020-05-05 開始されました Chardan Capital Markets Buy
2020-01-30 開始されました Canaccord Genuity Buy
2020-01-09 アップグレード UBS Neutral → Buy
2019-11-07 繰り返されました H.C. Wainwright Buy
2019-06-25 開始されました Stifel Hold
2019-06-10 アップグレード B. Riley FBR Neutral → Buy
2019-02-28 繰り返されました H.C. Wainwright Buy
2019-02-22 開始されました SVB Leerink Outperform
2019-01-23 開始されました UBS Neutral
2018-12-14 開始されました Wolfe Research Outperform
2018-12-12 開始されました B. Riley FBR Neutral
2018-11-19 ダウングレード Raymond James Mkt Perform → Underperform
2018-11-16 アップグレード Evercore ISI In-line → Outperform
2018-09-04 開始されました Citigroup Buy
2018-08-06 ダウングレード Goldman Buy → Neutral
2018-06-28 開始されました Raymond James Mkt Perform
すべてを表示

Madrigal Pharmaceuticals Inc (MDGL) 最新ニュース

pulisher
Mar 28, 2025

Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Madrigal (MDGL) Up 0.5% Since Last Earnings Report: Can It Continue? - Nasdaq

Mar 28, 2025
pulisher
Mar 25, 2025

Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long - Simply Wall St

Mar 25, 2025
pulisher
Mar 21, 2025

(MDGL) On The My Stocks Page - Stock Traders Daily

Mar 21, 2025
pulisher
Mar 20, 2025

EU health regulator clears use of AI tool in fatty liver disease trials - Reuters

Mar 20, 2025
pulisher
Mar 18, 2025

Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 18, 2025
pulisher
Mar 15, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 15, 2025
pulisher
Mar 15, 2025

Madrigal Pharmaceuticals Announces Changes to Board of Directors - MSN

Mar 15, 2025
pulisher
Mar 14, 2025

Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential - Investing.com India

Mar 13, 2025
pulisher
Mar 12, 2025

Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Victory Capital Management Inc. Has $21.80 Million Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Bank of New York Mellon Corp Lowers Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Madrigal Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

How the (MDGL) price action is used to our Advantage - Stock Traders Daily

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Pharmaceuticals Expands Board with New Appointment - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal appoints Jacqualyn Fouse to its board -March 11, 2025 at 09:36 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Appoints Jacqualyn A. Fouse, Ph.D. To Board - citybiz

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Pharmaceuticals appoints new board member - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Why Madrigal Pharmaceuticals (MDGL) Stock is Rising Today - GuruFocus.com

Mar 11, 2025
pulisher
Mar 10, 2025

Robert E. Waltermire Sells 14,113 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, - GuruFocus.com

Mar 09, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals Exec Cashes Out in Multi-Million Dollar Stock Sale! - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Holdings Reduced by Principal Financial Group Inc. - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Madrigal Pharmaceuticals CFO Mardi sells $637,247 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Madrigal Pharmaceuticals exec sells $418,488 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 04, 2025

Madrigal Pharmaceuticals exec sells $418,488 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 6.8% on Insider Selling - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

B. Riley Analysts Increase Earnings Estimates for MDGL - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Sanctuary Advisors LLC Acquires 62 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

HC Wainwright Issues Negative Estimate for MDGL Earnings - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch - MSN

Mar 02, 2025
pulisher
Mar 01, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives $351.67 Consensus PT from Analysts - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

New York State Common Retirement Fund Sells 5,630 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Citigroup Boosts Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $469.00 - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock By Investing.com - Investing.com Australia

Feb 28, 2025
pulisher
Feb 28, 2025

(MDGL) Trading Report - Stock Traders Daily

Feb 28, 2025
pulisher
Feb 28, 2025

Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Citigroup Issues Positive Forecast for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price - MarketBeat

Feb 28, 2025

Madrigal Pharmaceuticals Inc (MDGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Madrigal Pharmaceuticals Inc (MDGL) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
CRAVES FRED B
Director
Mar 13 '25
Option Exercise
65.06
7,742
503,695
357,818
CRAVES FRED B
Director
Mar 12 '25
Sale
331.84
7,728
2,564,426
350,076
CRAVES FRED B
Director
Mar 13 '25
Sale
325.25
7,742
2,518,053
350,076
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):